{"id": "F3.2-000162-P1", "question": "Which drugs target both HDAC8 and HDAC9?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN t.name AS therapy_name\nLIMIT 100", "gold_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "generated_rows": [{"therapy_name": "Abexinostat"}, {"therapy_name": "Belinostat"}, {"therapy_name": "Panobinostat"}], "error": null}
{"id": "F3.2-000005-P1", "question": "Which drugs target both ALK and EML4?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN t.name AS therapy_name\nLIMIT 100", "gold_rows": [{"gene_symbol": "ALK", "therapy_name": "Alectinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Ceritinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Crizotinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Lorlatinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"]}], "generated_rows": [{"therapy_name": "Alectinib"}, {"therapy_name": "Ceritinib"}, {"therapy_name": "Crizotinib"}, {"therapy_name": "Lorlatinib"}], "error": null}
{"id": "F3.1-000046-P3", "question": "Show treatments that target FGFR2 or FGFR3.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('FGFR2')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\n  OR toLower(g.symbol) = toLower('FGFR3')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('FGFR2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\nWITH t, g, r\nMATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('FGFR3')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\nRETURN\n  NULL AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  NULL AS effect,\n  NULL AS disease_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Lucitanib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://bit.ly/1ZGqyT3", "21212416", "22304225"], "ref_urls": ["http://bit.ly/1ZGqyT3", "http://europepmc.org/abstract/MED/21212416", "http://europepmc.org/abstract/MED/22304225"]}, {"gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR2", "therapy_name": "TRK Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}, {"gene_symbol": "FGFR3", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Dovitinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pazopanib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR3", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"variant_name": null, "gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "effect": null, "disease_name": null, "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "error": null}
{"id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = toLower('resistance')\nAND (toLower(t.name) = toLower('Platinum Compound') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound')) OR any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS toLower('platinum')))\nAND toLower(rel.disease_name) CONTAINS toLower('ovarian') AND toLower(rel.disease_name) CONTAINS toLower('serous') AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\nCASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\nCASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\nt.name AS therapy_name,\nrel.effect AS effect,\nrel.disease_name AS disease_name,\ncoalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [{"variant_name": "AURKA Overexpression", "gene_symbol": "AURKA", "therapy_name": "Platinum Compound", "effect": "resistance", "disease_name": "Ovarian Serous Carcinoma", "pmids": ["27209210"]}], "error": null}
{"id": "F4.2-000184-P3", "question": "Find therapies that target resistance genes for Imatinib in Melanoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('imatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib'))\n  OR toLower(t.name) CONTAINS toLower('imatinib')\n)\nAND toLower(rel.effect) = toLower('resistance')\nAND toLower(rel.disease_name) CONTAINS toLower('melanoma')\nMATCH (t)-[:TARGETS]->(g:Gene)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Amuvatinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Avapritinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "C-Met Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Cediranib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Crenolanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://arogpharma.com/crenolanib", "22745105", "24623852"], "ref_urls": ["http://arogpharma.com/crenolanib", "http://europepmc.org/abstract/MED/22745105", "http://europepmc.org/abstract/MED/24623852"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Dovitinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Foretinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Linifanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["16648571", "17343372"], "ref_urls": ["http://europepmc.org/abstract/MED/16648571", "http://europepmc.org/abstract/MED/17343372"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Midostaurin", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Motesanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Nintedanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Pazopanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Quizartinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Ripretinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Sunitinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor | Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "TRK Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Vatalanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Mucosal Melanoma", "pmids": ["23775962"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21642685"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["19671763"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24132921"]}], "error": null}
{"id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t2:Therapy)\nWHERE toLower(rel.effect) = toLower('resistance')\nAND toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma')\nMATCH (t2)-[:TARGETS]->(g:Gene)\nWHERE toLower(t2.name) = toLower('Dasatinib')\n   OR any(s IN coalesce(t2.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n   OR toLower(t2.name) CONTAINS toLower('Dasatinib')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g2:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g2.symbol END AS gene_symbol,\n  t2.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [], "error": null}
{"id": "F4.2-000042-P3", "question": "Find therapies that target resistance genes for Gemcitabine in Pancreatic Adenocarcinoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Gemcitabine')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n  OR toLower(t1.name) CONTAINS toLower('Gemcitabine')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Gemcitabine')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Gemcitabine')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n    OR toLower(t.name) CONTAINS toLower('Gemcitabine')\n  )\n  AND toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('pancreatic')\n  AND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["24915778"]}, {"variant_name": "RB1 Overexpression", "gene_symbol": "RB1", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["11792751"]}], "error": null}
{"id": "F4.1-000072-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Stromal Tumour Of Gastrointestinal Tract.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'gastrointestinal' AND\n    toLower(rel.disease_name) CONTAINS 'stromal' AND\n    toLower(rel.disease_name) CONTAINS 'tumor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('stromal')\n  AND toLower(rel.disease_name) CONTAINS toLower('tumour')\n  AND toLower(rel.disease_name) CONTAINS toLower('gastrointestinal')\n  AND toLower(rel.disease_name) CONTAINS toLower('tract')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE gene.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Gastrointestinal Stromal Tumor", "pmids": ["40900786"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000096", "question": "Which therapies target ALK and also have biomarker evidence in Glioblastoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nOPTIONAL MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('glioblastoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene:Gene)\nRETURN\n    CASE WHEN b IS NOT NULL AND b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    CASE WHEN rel IS NOT NULL THEN rel.effect ELSE NULL END AS effect,\n    CASE WHEN rel IS NOT NULL THEN rel.disease_name ELSE NULL END AS disease_name,\n    r.moa AS targets_moa,\n    coalesce(r.ref_sources, []) AS ref_sources,\n    coalesce(r.ref_ids, []) AS ref_ids,\n    coalesce(r.ref_urls, []) AS ref_urls,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ALK", "therapy_name": "ALK Inhibitor ASP3026", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["24419060"], "ref_urls": ["http://europepmc.org/abstract/MED/24419060"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Brigatinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.ariad.com/AP26113", "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf", "25888090"], "ref_urls": ["http://europepmc.org/abstract/MED/25888090", "http://www.ariad.com/AP26113", "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"], "pmids": []}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"], "pmids": []}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"], "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"], "pmids": ["22162573"]}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": null, "disease_name": null, "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.xcovery.com/our-science/alk-inhibitor/", "25322323"], "ref_urls": ["http://europepmc.org/abstract/MED/25322323", "http://www.xcovery.com/our-science/alk-inhibitor/"], "pmids": []}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212725s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"], "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212725s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"], "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"], "pmids": ["30171048"]}], "error": null}
{"id": "F2.2-000010-S1-P1", "question": "What is the effect of RET G810S on Selpercatinib in Thyroid Gland Medullary Carcinoma?", "gold_cypher": "MATCH (v:Variant {name: 'RET G810S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selpercatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib'))\n  OR toLower(t.name) CONTAINS toLower('Selpercatinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'medullary' AND\n    toLower(rel.disease_name) CONTAINS 'thyroid' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('RET') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RET')))\nAND (toLower(v.name) CONTAINS toLower('G810S') OR v.hgvs_p = 'p.G810S' OR any(s IN coalesce(v.synonyms, []) WHERE toLower(s) = toLower('G810S')))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (toLower(t.name) = toLower('Selpercatinib') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib')) OR toLower(t.name) CONTAINS toLower('Selpercatinib'))\nAND toLower(rel.disease_name) CONTAINS toLower('thyroid')\nAND toLower(rel.disease_name) CONTAINS toLower('gland')\nAND toLower(rel.disease_name) CONTAINS toLower('medullary')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nRETURN\n    v.name AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RET G810S", "gene_symbol": "RET", "therapy_name": "Selpercatinib", "effect": "resistance", "disease_name": "Medullary Thyroid Carcinoma", "pmids": ["33161056"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000017-S1-P2", "question": "Does TP53 Mutation predict response to Eprenetapopt in Malignant Tumor?", "gold_cypher": "MATCH (v:Variant {name: 'TP53 Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Eprenetapopt')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Eprenetapopt'))\n  OR toLower(t.name) CONTAINS toLower('Eprenetapopt')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TP53')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TP53'))\nAND toLower(v.name) CONTAINS toLower('Mutation')\nWITH v\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE b = v\nAND (toLower(t.name) = toLower('Eprenetapopt')\n     OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Eprenetapopt'))\n     OR toLower(t.name) CONTAINS toLower('Eprenetapopt'))\nAND toLower(rel.disease_name) CONTAINS toLower('malignant')\nAND toLower(rel.disease_name) CONTAINS toLower('tumor')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["36084396"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Ovarian Cancer", "pmids": ["26086967"]}], "generated_rows": [], "error": null}
{"id": "F1.3-000120-P1", "question": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T belongs to which gene?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE v.name = 'PIK3CA H1047R' OR v.name = 'PIK3CA H1047Y' OR v.name = 'PIK3CA H1047L' OR v.name = 'PIK3CA H1047D' OR v.name = 'PIK3CA H1047I' OR v.name = 'PIK3CA H1047N' OR v.name = 'PIK3CA H1047P' OR v.name = 'PIK3CA H1047Q' OR v.name = 'PIK3CA H1047T'\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100", "gold_rows": [{"gene_symbol": "PIK3CA", "variant_name": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T"}], "generated_rows": [{"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA"}, {"variant_name": "PIK3CA H1047Y", "gene_symbol": "PIK3CA"}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA"}], "error": null}
{"id": "F2.2-000180-P3", "question": "What genes are resistance biomarkers for Erlotinib in Lung Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Erlotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Erlotinib'))\n  OR toLower(t.name) CONTAINS toLower('Erlotinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Erlotinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Erlotinib'))\n    OR toLower(t.name) CONTAINS toLower('Erlotinib')\n  )\n  AND toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('cancer')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["24353160", "23371856", "16407879", "26096453", "22895145", "26773740", "27032107", "23470965", "17085664", "19010870"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006", "17877814", "17085664", "24353160", "19147750", "19786660", "21841502", "25668228", "27304188", "15737014"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Acinar Adenocarcinoma", "pmids": ["23181703"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["16818618"]}, {"variant_name": null, "gene_symbol": "FGFR4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["31027687"]}, {"variant_name": null, "gene_symbol": "GNAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24758907"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15696205", "22982650", "24351425", "21969500", "22025157"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["19794967"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["16043828", "2199829"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "NRG1", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["27304188"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21258250"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["16043828", "2199829"]}], "error": null}
{"id": "F2.4-000056-P2", "question": "Report the consequence for VHL c.340+770T>C.", "gold_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)\nWHERE toLower(v.name) = toLower('c.340+770T>C')\nRETURN v.consequence AS consequence\nLIMIT 100", "gold_rows": [{"variant_name": "VHL c.340+770T>C", "variant_consequence": null}], "generated_rows": [], "error": null}
{"id": "F2.4-000035", "question": "What is the consequence of the EGFR R705K variant?", "gold_cypher": "MATCH (v:Variant {name: 'EGFR R705K'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('EGFR') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR')))\nAND toLower(v.name) = toLower('EGFR R705K')\nRETURN v.consequence\nLIMIT 100", "gold_rows": [{"variant_name": "EGFR R705K", "variant_consequence": null}], "generated_rows": [{"v.consequence": null}], "error": null}
{"id": "F6.2-000012-S1-P3", "question": "Show treatments for TOP1 excluding HDAC1 that have biomarker evidence in Ureteral Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('ureteral')\n  AND toLower(rel.disease_name) CONTAINS toLower('small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000015-S1-P1", "question": "Which therapies have variant biomarkers in Squamous Cell Carcinomas Of Head And Neck?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('squamous')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinomas')\n  AND toLower(rel.disease_name) CONTAINS toLower('head')\n  AND toLower(rel.disease_name) CONTAINS toLower('neck')\nMATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE b:Variant\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25892145"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Alisertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "HRAS G12V", "gene_symbol": "HRAS", "therapy_name": "Alpelisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30115483"]}, {"variant_name": "PIK3CA E542K", "gene_symbol": "PIK3CA", "therapy_name": "Apitolisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26787751"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Barasertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Celecoxib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577089"]}, {"variant_name": "EGF EXPRESSION", "gene_symbol": "EGF", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25677871"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039", "27207775"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR P546S", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23578570"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "NRAS G13V", "gene_symbol": "NRAS", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28259104"]}, {"variant_name": "SMAD4 Underexpression", "gene_symbol": "SMAD4", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26046389"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "KRAS RS61764370", "gene_symbol": "KRAS", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25081901"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Copanlisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577117"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "MAPK1 E278E", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029"]}, {"variant_name": "MAPK1 E322K", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029", "27004400"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Ibuprofen", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26015511"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "JSI-124", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "ERBB2 Overexpression", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28061634"]}, {"variant_name": "NRG1 Expression", "gene_symbol": "NRG1", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21840482"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Leucovorin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "FGFR2 P253R", "gene_symbol": "FGFR2", "therapy_name": "Pazopanib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23786770"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Platinum Compound", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "NOTCH1 Loss-of-function", "gene_symbol": "NOTCH1", "therapy_name": "Porcupine Inhibitor WNT974", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24277854"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Radiation Therapy", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28476872"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Radiation Therapy", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "Stattic", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Taselisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "HRAS Mutation", "gene_symbol": "HRAS", "therapy_name": "Tipifarnib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["33750196"]}, {"variant_name": "ALDH1A2 Underexpression", "gene_symbol": "ALDH1A2", "therapy_name": "Tretinoin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26634247"]}], "generated_rows": [], "error": null}
{"id": "F6.3-000155-P1", "question": "Which therapies targeting POLD3 have variant-level resistance in Pancreatic Adenocarcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('pancreatic')\n  AND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [], "generated_rows": [{"variant_name": "KRAS G12/G13", "gene_symbol": "POLD3", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["24915778"]}, {"variant_name": "RB1 Overexpression", "gene_symbol": "POLD3", "therapy_name": "Gemcitabine", "effect": "resistance", "disease_name": "Pancreatic Adenocarcinoma", "pmids": ["11792751"]}], "error": null}
{"id": "F6.1-000125-S1-P1", "question": "In Naevocarcinoma, which genes confer resistance to Vemurafenib or Dabrafenib?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Vemurafenib')\n    OR toLower(t.name) = toLower('Dabrafenib')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Vemurafenib'))\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('Dabrafenib'))\n    OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n    OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n  )\n  AND toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24055054", "25452114", "23237741"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25452114", "24265153"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23171796"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "25452114"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "AEBP1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24201813"]}, {"variant_name": null, "gene_symbol": "AGK", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23890088"]}, {"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24265152"]}, {"variant_name": null, "gene_symbol": "AKT3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "26070258", "25515853", "24112705", "24055054", "24576830", "22113612"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "CIC", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["21107323"]}, {"variant_name": null, "gene_symbol": "GNAQ", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24504448"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21383288", "23569304", "24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["26359985", "23802768"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23288408", "23171796"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23288408"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "23569304", "21107323", "22395615", "20149136", "28783719"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23948972", "22194965"]}, {"variant_name": null, "gene_symbol": "PAPSS1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24345920"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PIK3R2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PREX2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "RAF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27273450"]}, {"variant_name": null, "gene_symbol": "SOX10", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24670642"]}, {"variant_name": null, "gene_symbol": "STAG2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "STAG3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "TF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "TRIM24", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24345920"]}], "generated_rows": [], "error": null}
{"id": "F6.1-000014-S1-P2", "question": "List resistance genes for Platinum Doublet or Dacomitinib in Non-small Cell Lung Cancer.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Platinum Doublet')\n  OR toLower(t.name) = toLower('Dacomitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Platinum Doublet'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dacomitinib'))\n  OR toLower(t.name) CONTAINS toLower('Platinum Doublet')\n  OR toLower(t.name) CONTAINS toLower('Dacomitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = toLower('resistance')\nAND (\n  toLower(t.name) = toLower('Platinum Doublet')\n  OR toLower(t.name) = toLower('Dacomitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Platinum Doublet'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dacomitinib'))\n  OR toLower(t.name) CONTAINS toLower('Platinum Doublet')\n  OR toLower(t.name) CONTAINS toLower('Dacomitinib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('cancer')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": null, "gene_symbol": "NFE2L2", "therapy_name": "Platinum Doublet", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31548347"]}], "generated_rows": [], "error": null}
{"id": "F6.4-000002-P2", "question": "Which treatments target resistance biomarkers for Pemetrexed in Lung Non-small Cell Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Pemetrexed')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Pemetrexed'))\n  OR toLower(t1.name) CONTAINS toLower('Pemetrexed')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Pemetrexed')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('pemetrexed')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('pemetrexed'))\n  )\n  AND toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('non-small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "TYMS", "therapy_name": "Capecitabine", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Fluorouracil", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Raltitrexed", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12056700", "9579851"], "ref_urls": ["http://europepmc.org/abstract/MED/12056700", "http://europepmc.org/abstract/MED/9579851"]}, {"gene_symbol": "TYMS", "therapy_name": "Tegafur", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["EMA"], "ref_ids": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"], "ref_urls": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"]}], "generated_rows": [{"variant_name": "TYMS Overexpression", "gene_symbol": "TYMS", "therapy_name": "Pemetrexed", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26502926", "23060591"]}], "error": null}
{"id": "F6.4-000173-S1", "question": "For resistance to MUC1-targeted Peptide GO-203-2C in Non-small Cell Lung Carcinoma, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('MUC1-targeted Peptide GO-203-2C')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('MUC1-targeted Peptide GO-203-2C'))\n  OR toLower(t1.name) CONTAINS toLower('MUC1-targeted Peptide GO-203-2C')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('MUC1-targeted Peptide GO-203-2C')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('GO-203-2C')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('GO-203-2C'))\n    OR toLower(t.name) CONTAINS toLower('GO-203-2C')\n  )\n  AND toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('non-small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nMATCH (tt:Therapy)-[:TARGETS]->(g:Gene)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE gg.symbol END AS gene_symbol,\n  tt.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "ALK Inhibitor ASP3026", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "ARQ092", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "ARQ092", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "ARQ092", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "ATR Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "AZD-4547", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "AZD-4547", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "AZD-4547", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "AZD-4547", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abemaciclib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abemaciclib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abexinostat", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Abiraterone Acetate", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Adagrasib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Adavosertib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afimoxifene", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afimoxifene", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Afimoxifene", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Agerafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Agerafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Agerafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Akt Inhibitor MK2206", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Akt Inhibitor MK2206", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Akt Inhibitor MK2206", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alemtuzumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alisertib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alpelisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvespimycin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvespimycin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Alvocidib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aminoglutethimide", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aminoglutethimide", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amivantamab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amivantamab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amrubicin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amuvatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amuvatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amuvatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Amuvatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Angiogenesis Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Angiogenesis Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Angiogenesis Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Anti-PD1 Monoclonal Antibody", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apalutamide", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Apitolisib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aromatase Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Arsenic Trioxide", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Asciminib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Asciminib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aspirin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aspirin", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Atezolizumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Aumolertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Avapritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Avapritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Avelumab", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Azacitidine", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Azacitidine", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "Azathioprine", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "BET Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "BET Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}, {"variant_name": "KRAS G12S", "gene_symbol": "KRAS", "therapy_name": "BET Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25245423"]}], "error": null}
{"id": "F6.4-000094", "question": "For resistance to Cetuximab in Ovarian Cancer, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Cetuximab')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Cetuximab'))\n  OR toLower(t1.name) CONTAINS toLower('Cetuximab')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Cetuximab')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('cetuximab')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('cetuximab'))\n    OR toLower(t.name) CONTAINS toLower('cetuximab')\n  )\n  AND toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('ovarian')\n  AND toLower(rel.disease_name) CONTAINS toLower('cancer')\nMATCH (t2:Therapy)-[:TARGETS]->(g:Gene)\nWHERE b.symbol = g.symbol\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g2:Gene)\nRETURN\n    CASE WHEN b:Gene THEN b.symbol ELSE g2.symbol END AS gene_symbol,\n    t2.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000187-S2-P3", "question": "What genes are sensitivity biomarkers for Ponatinib in Acute Myeloblastic Leukaemia?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ponatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ponatinib'))\n  OR toLower(t.name) CONTAINS toLower('Ponatinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('ponatinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('ponatinib'))\n    OR toLower(t.name) CONTAINS toLower('ponatinib')\n  )\n  AND toLower(rel.effect) = 'sensitivity'\n  AND toLower(rel.disease_name) CONTAINS toLower('acute')\n  AND toLower(rel.disease_name) CONTAINS toLower('myeloblastic')\n  AND toLower(rel.disease_name) CONTAINS toLower('leukaemia')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1OP2", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FIP1L1", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060", "21482694", "23430109"]}, {"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000019-S1-P3", "question": "What genes are sensitivity biomarkers for Pictilisib in Malignant Neoplasm Of Breast?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND toLower(rel.disease_name) CONTAINS toLower('malignant')\nAND toLower(rel.disease_name) CONTAINS toLower('neoplasm')\nAND toLower(rel.disease_name) CONTAINS toLower('breast')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22802530"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058", "23888070"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000095", "question": "Which genes affect response to Onartuzumab in Gastric Adenocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Onartuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Onartuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Onartuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Onartuzumab')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Onartuzumab'))\n    OR toLower(t.name) CONTAINS toLower('Onartuzumab')\n  )\n  AND toLower(rel.disease_name) CONTAINS toLower('gastric')\n  AND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": null, "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "error": null}
{"id": "F2.2-000064-P2", "question": "Which genes influence response to MTOR Kinase Inhibitor AZD8055 for Breast Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MTOR Kinase Inhibitor AZD8055')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MTOR Kinase Inhibitor AZD8055'))\n  OR toLower(t.name) CONTAINS toLower('MTOR Kinase Inhibitor AZD8055')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('AZD8055')\n    OR any(s IN coalesce(t.synonyms, [])\n           WHERE toLower(s) = toLower('AZD8055'))\n  )\n  AND (\n    any(tag IN coalesce(t.tags, [])\n        WHERE toLower(tag) CONTAINS toLower('MTOR Kinase Inhibitor'))\n    OR (t)-[:TARGETS]->(:Gene {symbol: 'MTOR'})\n  )\n  AND toLower(rel.disease_name) CONTAINS toLower('breast')\n  AND toLower(rel.disease_name) CONTAINS toLower('cancer')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": null, "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "error": null}
{"id": "F2.2-000038-S1-P2", "question": "Which genes influence response to Vemurafenib for Childhood Ganglioglioma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Vemurafenib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n    OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n  )\nAND toLower(rel.disease_name) CONTAINS toLower('childhood')\nAND toLower(rel.disease_name) CONTAINS toLower('ganglioglioma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": null, "disease_name": "Ganglioglioma", "pmids": ["26579623", "31985841", "30120137"]}], "generated_rows": [], "error": null}
{"id": "F2.3-000165-P2", "question": "What PMIDs support resistance of Axitinib due to BCR BCR::ABL1 Fusion AND ABL1 F311I?", "gold_cypher": "MATCH (v:Variant {name: 'BCR BCR::ABL1 Fusion AND ABL1 F311I'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Axitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Axitinib'))\n  OR toLower(t.name) CONTAINS toLower('Axitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('axitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('axitinib'))\n  OR toLower(t.name) CONTAINS toLower('axitinib')\n)\nWITH b, rel, t\nMATCH (v1:Variant)-[:VARIANT_OF]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('BCR')\n  AND (toLower(v1.name) CONTAINS toLower('BCR::ABL1') OR toLower(v1.name) CONTAINS toLower('ABL1::BCR'))\nWITH b, rel, t, v1, g1\nMATCH (v2:Variant)-[:VARIANT_OF]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('ABL1')\n  AND (toLower(v2.name) CONTAINS toLower('F311I') OR v2.hgvs_p = 'p.F311I' OR any(s IN coalesce(v2.synonyms, []) WHERE toLower(s) CONTAINS toLower('F311I')))\nWITH b, rel, t, v1, g1, v2, g2\nWHERE b = v1 OR b = v2\nAND toLower(rel.effect) = toLower('resistance')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000112-S1", "question": "Which genes predict sensitivity to Fexagratinib in Squamous Cell Carcinoma Of The Cervix Uteri?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Fexagratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'cervical' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Fexagratinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n    OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n  )\n  AND toLower(rel.effect) = 'sensitivity'\n  AND toLower(rel.disease_name) CONTAINS toLower('squamous')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('cervix')\n  AND toLower(rel.disease_name) CONTAINS toLower('uteri')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Fexagratinib", "effect": "sensitivity", "disease_name": "Cervical Squamous Cell Carcinoma", "pmids": ["32463741"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000095-P3", "question": "How does FLT3 S574 influence response to Midostaurin for Acute Myeloid Leukemia?", "gold_cypher": "MATCH (v:Variant {name: 'FLT3 S574'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Midostaurin')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Midostaurin'))\n  OR toLower(t.name) CONTAINS toLower('Midostaurin')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('FLT3') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FLT3')))\nAND (toLower(v.name) CONTAINS toLower('S574') OR v.hgvs_p = 'p.S574' OR any(s IN coalesce(v.synonyms, []) WHERE toLower(s) = toLower('S574')))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (toLower(t.name) = toLower('Midostaurin') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Midostaurin')) OR toLower(t.name) CONTAINS toLower('Midostaurin'))\nAND toLower(rel.disease_name) CONTAINS toLower('acute')\nAND toLower(rel.disease_name) CONTAINS toLower('myeloid')\nAND toLower(rel.disease_name) CONTAINS toLower('leukemia')\nRETURN\n    v.name AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}], "generated_rows": [{"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15374944"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["28644114", "32754299"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["28644114"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["28644114"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["16150941"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["28546144"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15178581", "40196870"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["20733134"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}, {"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15345593"]}], "error": null}
{"id": "F2.2-000090-S2-P2", "question": "Does PTEN Loss predict response to Everolimus in Mammary Tumor?", "gold_cypher": "MATCH (v:Variant {name: 'PTEN Loss'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Everolimus')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n    OR toLower(t.name) CONTAINS toLower('Everolimus')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) CONTAINS toLower('Everolimus'))\n  )\n  AND toLower(rel.disease_name) CONTAINS toLower('mammary')\n  AND toLower(rel.disease_name) CONTAINS toLower('tumor')\n  AND (toLower(b.name) CONTAINS toLower('loss') OR toLower(b.synonyms) CONTAINS toLower('loss'))\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PTEN')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PTEN'))\nWITH b, rel, t, g\nWHERE (b:Gene AND (toLower(b.symbol) = toLower('PTEN') OR any(s IN coalesce(b.synonyms, []) WHERE toLower(s) = toLower('PTEN'))))\n   OR (b:Variant AND g IS NOT NULL AND (toLower(g.symbol) = toLower('PTEN') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PTEN'))))\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["27091708"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["21358673"]}], "generated_rows": [], "error": null}
